KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Non-Current Deffered Revenue (2017 - 2025)

Historic Non-Current Deffered Revenue for Cardlytics (CDLX) over the last 8 years, with Q3 2025 value amounting to $62000.0.

  • Cardlytics' Non-Current Deffered Revenue changed N/A to $62000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $62000.0, marking a year-over-year change of. This contributed to the annual value of $67000.0 for FY2023, which is 7994.01% down from last year.
  • According to the latest figures from Q3 2025, Cardlytics' Non-Current Deffered Revenue is $62000.0.
  • Cardlytics' 5-year Non-Current Deffered Revenue high stood at $334000.0 for Q4 2022, and its period low was $30000.0 during Q2 2024.
  • For the 5-year period, Cardlytics' Non-Current Deffered Revenue averaged around $105615.4, with its median value being $81000.0 (2023).
  • In the last 5 years, Cardlytics' Non-Current Deffered Revenue tumbled by 7994.01% in 2023 and then soared by 15000.0% in 2025.
  • Cardlytics' Non-Current Deffered Revenue (Quarter) stood at $173000.0 in 2021, then surged by 93.06% to $334000.0 in 2022, then crashed by 79.94% to $67000.0 in 2023, then tumbled by 55.22% to $30000.0 in 2024, then soared by 106.67% to $62000.0 in 2025.
  • Its last three reported values are $62000.0 in Q3 2025, $75000.0 for Q2 2025, and $30000.0 during Q2 2024.